Merck KGaA (MKGAF)
OTCMKTS
· Delayed Price · Currency is USD
141.27
-2.03 (-1.42%)
Dec 23, 2024, 3:00 PM EST
Merck KGaA Revenue
Merck KGaA had revenue of 5.27B EUR in the quarter ending September 30, 2024, with 1.80% growth. This brings the company's revenue in the last twelve months to 20.96B, down -2.17% year-over-year. In the year 2023, Merck KGaA had annual revenue of 20.99B, down -5.57%.
Revenue (ttm)
20.96B EUR
Revenue Growth
-2.17%
P/S Ratio
n/a
Revenue / Employee
333.23K EUR
Employees
62,908
Market Cap
62.31B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 20.99B | -1.24B | -5.57% |
Dec 31, 2022 | 22.23B | 2.55B | 12.93% |
Dec 31, 2021 | 19.69B | 2.15B | 12.28% |
Dec 31, 2020 | 17.53B | 1.38B | 8.56% |
Dec 31, 2019 | 16.15B | 1.32B | 8.87% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sandoz Group AG | 10.11B |
Telix Pharmaceuticals Limited | 430.80M |
Elekta AB (publ) | 1.66B |
Ryman Healthcare Limited | 458.44M |
Verano Holdings Corp. | 897.57M |
Vireo Growth Inc. | 98.53M |
Medexus Pharmaceuticals Inc. | 104.76M |
Merck KGaA News
- 7 days ago - MilliporeSigma to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio - Financial Post
- 5 weeks ago - Merck KGaA (MKGAF) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Merck KGaA 2024 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 5 weeks ago - Merck KGaA continues focus on strengthening pipeline with external innovation, says CFO on drug trials - CNBC
- 5 weeks ago - Merck KGaA Non-GAAP EPS of €2.30, revenue of €5.27B; updates FY24 outlook - Seeking Alpha
- 5 weeks ago - Merck KGaA Q3 earnings rise faster than expected on lower costs - Reuters
- 5 weeks ago - Merck KGaA Specifies Guidance Amid Soft Semiconductor Market - BNN Bloomberg
- 6 weeks ago - Merck KGaA, Darmstadt, Germany and Intel Launch Academic Research Program in Europe for More Sustainable Semiconductor Manufacturing - Financial Post